Learn more and register here.

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for hematologic malignancies. FREE for healthcare professionals, students, patients and patient advocates.

New for 2025

• View the most up-to-date information on currently approved immunotherapies for lymphoma, multiple myeloma, and leukemia, as well as emerging data from ongoing trials of new immunotherapy-based approaches to treat these cancers.
• Discuss the use of therapies in real-world clinical settings, including addressing resistance and relapse, managing toxicities, and managing T cell-directed therapies in the outpatient setting.